WebJun 28, 2016 · The median number of hospitalizations is 1 in the carboplatin/etoposide group versus 2 in the cisplatin/etoposide group with an odds ratio of 0.76 (95% CI, 0.65 to 0.9). For ED visits, the medians are 1 in carboplatin/etoposide and 2 is cisplatin etoposide, yielding an odds ratio of 0.82 (95% CI, 0.7 to 0.96). WebCISplatin is administered on day 1 and etoposide is administered on three consecutive days (Days 1-3) of a 21 day cycle for 4 cycles. Facilities to treat anaphylaxis MUST be …
Cisplatin (Intravenous Route) Side Effects - Mayo Clinic
WebSep 15, 2024 · Cisplatin is the prototype platinum coordination complex classified as an alkylating agent and used intravenously in the treatment of several forms of cancer. ... developed jaundice 1-5 months after starting etoposide with several other cyclic antineoplastic agents including cisplatin and cyclophosphamide in two [bilirubin 4.2-13.0 … WebOne regimen, which combined etoposide, doxorubicin, and cisplatin (EDP) with mitotane, had resulted in an objective response rate of 53% in a study involving 28 patients with advanced ... life is tech 個人
Etoposide and cisplatin chemotherapy for metastatic good-risk ... - PubMed
WebSep 21, 2016 · Purpose To assess response, overall survival, and relapse-free survival of patients with good-risk metastatic germ cell tumor (GCT) by International Germ Cell Consensus Classification Group (IGCCCG) criteria treated with four cycles of etoposide and cisplatin (EP). Patients and Methods Two hundred eighty-nine patients with IGCCCG … WebFeb 14, 2024 · Four cycles of etoposide and cisplatin (EPx4) is a standard-of-care regimen for all patients with good-risk germ cell tumors with a favorable response rate and disease-specific survival of 98%. Full-dose administration of etoposide and cisplatin and complete resection of residual disease lead to optimal outcomes. WebPurpose: The combination of etoposide (E) and cisplatin (P) is an accepted standard therapy for small-cell lung cancer (SCLC); however, the optimal sequencing and administration schedule has not been defined. This study was designed to evaluate different sequencing and administration schedules of E and P in the treatment of SCLC. ... mcswain fishing derby